The best trading indicator for TSLA (ad) |
Rarely do I label something as "the best'
But in this rare instance, I believe this is THE BEST indicator for trading Tesla's stock.
Except, it's not another tech stock…
But rather a stock hiding in broad daylight…
Click this link here. |
|
The World's First "$20 Trillion Drug"? (ad) |
The World's First "$20 Trillion Drug?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains!
Get the name of the stock here |
|
Apple Inc. (AAPL) Amazon.com, Inc. (AMZN) Alphabet Inc. (GOOGL) - CEO Sundar Pichai sold 22,500 shares of the company's stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $143.08, for a total transaction of $3,219,300.00. Following the transaction, the chief executive officer now owns 2,355,191 shares in the company, valued at $336,980,728.28. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
- insider John Kent Walker sold 48,076 shares of the company's stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $142.20, for a total value of $6,836,407.20. Following the sale, the insider now owns 12,725 shares in the company, valued at $1,809,495. The sale was disclosed in a legal filing with the SEC, which is available through this link.
- (2/23) Reddit's IPO Filing Puts These ETFs in Focus (zacks.com)
- (2/23) Alphabet target lifted as search resilience underappreciated - Redburn (investing.com)
- (2/23) 'It's Coming:' Elon Musk Hints At Launching 'XMail' As Alternative To Gmail Even As Google's Service Says It's 'Here To Say' (msn.com)
- (2/23) Google CEO Sundar Pichai Discusses AI's Key Role In Defending Against Cyber Threats (msn.com)
- (2/23) Google just can't seem to catch a break (businessinsider.com)
- (2/23) GOOG Stock Analysis: Why Right Now Is the Best Time to Buy Alphabet (investorplace.com)
- (2/23) 7 Stocks That Should Be on Every Investor's Must-Buy List (investorplace.com)
- (2/23) Rollins Financial Raises Holdings in Alphabet Inc. (NASDAQ:GOOGL) (marketbeat.com)
- (2/23) Reddit strikes $60M deal allowing Google to train AI models on its posts, unveils IPO plans (techxplore.com)
- (2/23) AI can 'disproportionately' help defend against cybersecurity threats, Google CEO Sundar Pichai says (cnbc.com)
Meta Platforms, Inc. (META) - insider Jennifer Newstead sold 585 shares of the business's stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $469.88, for a total value of $274,879.80. Following the completion of the transaction, the insider now owns 42,493 shares of the company's stock, valued at $19,966,610.84. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
- (2/23) Eagle Asset Management Inc. Has $28.39 Million Position in Meta Platforms, Inc. (NASDAQ:META) (marketbeat.com)
- (2/23) Instagram and Facebook knowingly platform parents who sexually exploit children for profit, say reports (msn.com)
- (2/23) Meta Staff Found Instagram Tool Enabled Child Exploitation. The Company Pressed Ahead Anyway. (wsj.com)
- (2/23) Meta Platforms, Inc. (META) Hit a 52 Week High, Can the Run Continue? (zacks.com)
- (2/23) Why this $4.5-billion money manager is adding Meta Platforms and trimming Apple (theglobeandmail.com)
- (2/23) Zacks.com featured highlights Netflix, Meta Platforms, Deckers Outdoor and GigaCloud Technology (finance.yahoo.com)
- (2/23) Meta Platforms, Inc. to Post Q1 2024 Earnings of $3.92 Per Share, Zacks Research Forecasts (NASDAQ:META) (marketbeat.com)
- (2/23) Meta's cross-platform initiative: Connecting Facebook and Instagram Threads for effortless content sharing (gadgetsnow.com)
- (2/23) Cost Controls and Margin Expansion Led Meta Platforms (META) to Outperform in 2023 (finance.yahoo.com)
Microsoft Co. (MSFT) - ATN International (NASDAQ:ATNI) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $40.00 price target on the stock, up previously from $39.00. This represents a 7.0% upside from the current price of $37.38.
- AXT (NASDAQ:AXTI) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $3.80 price target on the stock, up previously from $2.40. This represents a 2.3% downside from the current price of $3.89.
- AXT (NASDAQ:AXTI) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $3.75 price target on the stock, up previously from $2.25. This represents a 3.6% downside from the current price of $3.89.
- Church & Dwight (NYSE:CHD) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $115.00 price target on the stock. This represents a 15.1% upside from the current price of $99.94.
- Cenovus Energy (NYSE:CVE) (TSE:CVE) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.The current price is $17.54.
- Carvana (NYSE:CVNA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.The current price is $69.96.
- Carvana (NYSE:CVNA) was upgraded by analysts at Raymond James from an "underperform" rating to a "market perform" rating.The current price is $69.96.
- DraftKings (NASDAQ:DKNG) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $50.00 price target on the stock, up previously from $41.00. This represents a 18.1% upside from the current price of $42.33.
- Franklin Electric (NASDAQ:FELE) was upgraded by analysts at Northcoast Research from a "neutral" rating to a "buy" rating. They now have a $110.00 price target on the stock. This represents a 10.4% upside from the current price of $99.67.
- Fluence Energy (NASDAQ:FLNC) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $23.00 price target on the stock. This represents a 57.5% upside from the current price of $14.60.
- FOX (NASDAQ:FOXA) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $35.00 price target on the stock, up previously from $34.00. This represents a 15.5% upside from the current price of $30.29.
- Genmab A/S (NASDAQ:GMAB) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $48.00 price target on the stock, up previously from $46.00. This represents a 64.1% upside from the current price of $29.25.
- Huntsman (NYSE:HUN) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $32.00 price target on the stock, up previously from $25.00. This represents a 21.9% upside from the current price of $26.26.
- Mercedes-Benz Group (OTCMKTS:MBGYY) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
- Phillips Edison & Company, Inc. (NASDAQ:PECO) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating. They now have a $37.00 price target on the stock, up previously from $35.00. This represents a 6.2% upside from the current price of $34.85.
- Repsol (OTCMKTS:REPYY) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.The current price is $15.55.
- Ross Stores (NASDAQ:ROST) was upgraded by analysts at UBS Group AG from a "sell" rating to a "neutral" rating. They now have a $142.00 price target on the stock, up previously from $85.00. This represents a 4.4% downside from the current price of $148.48.
- AB SKF (publ) (OTCMKTS:SKFRY) was upgraded by analysts at UBS Group AG from a "sell" rating to a "buy" rating.The current price is $20.95.
- Block (NYSE:SQ) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $95.00 price target on the stock. This represents a 19.6% upside from the current price of $79.40.
- Summit Materials (NYSE:SUM) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to an "overweight" rating. They now have a $47.00 price target on the stock, up previously from $40.00. This represents a 10.1% upside from the current price of $42.69.
- View today's most recent analysts' upgrades at MarketBeat.com
Fox Couldn't Air my #1 A.I. Pick - Get it Here. (ad) |
50-year Wall Street Insider Marc Chaikin got invited onto Fox News to talk about A.I. - Here's what he couldn't say on television.
More here. |
|
- Applied Optoelectronics (NASDAQ:AAOI) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $16.00 price target on the stock, down previously from $22.00. This represents a 28.7% upside from the current price of $12.43.
- Allegion (NYSE:ALLE) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $141.00 price target on the stock, up previously from $140.00. This represents a 9.5% upside from the current price of $128.78.
- Altair Engineering (NASDAQ:ALTR) was downgraded by analysts at Rosenblatt Securities from a "buy" rating to a "neutral" rating. They now have a $88.00 price target on the stock, up previously from $74.00. This represents a 4.1% upside from the current price of $84.56.
- Boeing (NYSE:BA) was downgraded by analysts at Northcoast Research from a "buy" rating to a "neutral" rating.The current price is $201.36.
- Brighthouse Financial (NASDAQ:BHF) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $52.00 price target on the stock. This represents a 8.2% upside from the current price of $48.07.
- Fox Factory (NASDAQ:FOXF) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $55.00 price target on the stock. This represents a 18.9% upside from the current price of $46.24.
- TechnipFMC (NYSE:FTI) was downgraded by analysts at HSBC Holdings plc from a "buy" rating to a "hold" rating.The current price is $21.11.
- Johnson Controls International (NYSE:JCI) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $62.00 price target on the stock. This represents a 6.2% upside from the current price of $58.39.
- Liberty Global (NASDAQ:LBTYA) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating.The current price is $18.29.
- Pulmonx (NASDAQ:LUNG) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $14.00 price target on the stock, down previously from $16.00. This represents a 28.3% upside from the current price of $10.91.
- ModivCare (NASDAQ:MODV) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $39.00 price target on the stock, down previously from $60.00. This represents a 32.5% upside from the current price of $29.43.
- ModivCare (NASDAQ:MODV) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating. They now have a $40.00 price target on the stock, down previously from $60.00. This represents a 35.9% upside from the current price of $29.43.
- NIO (NYSE:NIO) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $5.00 price target on the stock, down previously from $8.50. This represents a 7.2% downside from the current price of $5.39.
- Sunnova Energy International (NYSE:NOVA) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating. They now have a $9.00 price target on the stock, down previously from $12.00. This represents a 18.4% upside from the current price of $7.60.
- Intellia Therapeutics (NASDAQ:NTLA) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $32.00 price target on the stock, down previously from $136.00. This represents a 24.3% upside from the current price of $25.75.
- Nutrien (NYSE:NTR) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $48.00 price target on the stock, down previously from $58.00. This represents a 9.3% downside from the current price of $52.94.
- Penumbra (NYSE:PEN) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $250.00 price target on the stock, down previously from $284.00. This represents a 1.3% upside from the current price of $246.69.
- Piedmont Lithium (NASDAQ:PLL) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.The current price is $12.40.
- Rivian Automotive (NASDAQ:RIVN) was downgraded by analysts at UBS Group AG from a "buy" rating to a "sell" rating. They now have a $8.00 price target on the stock, down previously from $24.00. This represents a 22.5% downside from the current price of $10.32.
- Vicor (NASDAQ:VICR) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating. They now have a $40.00 price target on the stock. This represents a 5.1% upside from the current price of $38.07.
- View today's most recent analysts' downgrades at MarketBeat.com
Do you know which numbers really enhance your trades? (ad) |
You might be surprised to learn that they aren't on an earnings report or a quarterly statement... Instead, they're living in the stock prices themselves! I'm Tom Busby, founder of the Diversified Trading Institute and with my "Little Black Book", you can learn how to harness the power of these key numbers today and enjoy a stronger trading account tomorrow!
Click here for your free copy now! |
|
- Adeia (NASDAQ:ADEA) is now covered by analysts at Rosenblatt Securities. They set a "buy" rating and a $15.00 price target on the stock. This represents a 33.0% upside from the current price of $11.28.
- BioNTech (NASDAQ:BNTX) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $127.00 price target on the stock. This represents a 35.5% upside from the current price of $93.70.
- Cantaloupe (NASDAQ:CTLP) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $10.00 price target on the stock. This represents a 52.4% upside from the current price of $6.56.
- i3 Verticals (NASDAQ:IIIV) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $28.00 price target on the stock. This represents a 24.2% upside from the current price of $22.54.
- Incyte (NASDAQ:INCY) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $81.00 price target on the stock. This represents a 32.1% upside from the current price of $61.33.
- Nuvalent (NASDAQ:NUVL) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $105.00 price target on the stock. This represents a 22.5% upside from the current price of $85.71.
- Novartis (NYSE:NVS) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $114.00 price target on the stock. This represents a 9.8% upside from the current price of $103.81.
- ORIC Pharmaceuticals (NASDAQ:ORIC) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.The current price is $10.92.
- Pfizer (NYSE:PFE) is now covered by analysts at Guggenheim. They set a "buy" rating and a $36.00 price target on the stock. This represents a 28.8% upside from the current price of $27.95.
- CPI Card Group (NASDAQ:PMTS) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $40.00 price target on the stock. This represents a 107.8% upside from the current price of $19.25.
- View today's most recent analysts' new coverage at MarketBeat.com
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: |
| - Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. - Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. - Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| START YOUR 30-DAY FREE TRIAL |
|
Upgrade Your Subscription |
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW |
|
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO |
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
JOIN NOW |
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2024 American Consumer News, LLC dba MarketBeat. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103 . United States. Today's Bonus Content: Multimillionaire Investor: "Hands Down the Most Lucrative Discovery of My Entire Career" |
|
No comments:
Post a Comment